Hims to cut 4% of workforce amid ban on weight-loss drug copies

Telehealth platform Hims & Hers will cut about 4% of its workforce, as it adjusts to a U.S. ban on manufacturing mass copies of the weight-loss drug Wegovy.

Trump pardons drive a big, burgeoning business for lobbyists

With President Donald Trump issuing pardons on a rolling basis, lobbyists say clients are willing to pay significant sums to get their cases in front of the president.

Volkswagen flags 'massive' U.S. investments and says tariff talks constructive

Several foreign companies have announced U.S. investments in response to Trump's tariffs, but German carmakers have been more cautious.

Ex-Goldman banker Leissner sentenced to two years in prison in 1MDB case

The former Goldman Sachs banker pleaded guilty in 2018 to a conspiracy to violate the Foreign Corrupt Practices Act and participating in a money laundering conspiracy.

These big international ETFs are outperforming the S&P 500. How to add this exposure to your portfolio

Big ETFs with a focus on China, Europe and Mexico are beating the S&P 500. It may be time for investors to rethink their international allocations.

Stocks making the biggest moves Thursday: Boeing, Nvidia, Salesforce, E.l.f. Beauty and more

These are the stocks posting the largest moves in midday trading.

An Abbott competitor drops out — plus, a special circumstance for Nvidia earnings

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.